To study the regulatory mechanisms for elevated CHCHD2 expression in hepatocytes of NASH liver, we treated primary hepatocytes with palmitate to induce lipotoxicity or LPS to induce inflammation. The gene discussed is CHCHD2; the disease is metabolic dysfunction-associated steatohepatitis.